Holiferm

About:

Holiferm develops holistically improved fermentation technology for massive economic improvements.

Top Investors: Greater Manchester Combined Authority, Clean Growth Fund, ICOS Capital Management, Biotechnology and Biological Sciences Research Council, Rhapsody Venture Partners

Description:

Holiferm is bringing biosurfactants to market and is in the process of building a ktonne scale sophorolipid manufacturing plant.

Total Funding Amount:

$32.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2018-05-01

Contact Email:

info(AT)holiferm.com

Founders:

Ben Dolman, Gustavo Valente, James Winterburn

Number of Employees:

11-50

Last Funding Date:

2023-12-06

IPO Status:

Private

Industries: